Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck Cancer

This study has been completed.

Study NCT00281866 Information provided by Sidney Kimmel Comprehensive Cancer Center

First Received: January 24, 2006 Last Updated: March 16, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given